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Kindler syndrome (OMIM 173650) is a rare autosomal recessive disorder characterized by trauma-induced blister
formation (especially in childhood) and photosensitivity. Other features include mucocutaneous scarring and
progressive poikiloderma. There is also an increased risk of skin and mucous membrane malignancy. The disorder
was recently mapped to 20p12.3 and pathogenic mutations were identiﬁed in a new gene, KIND1. This gene
encodes a 677 amino acid protein, kindlin-1, a component of focal contacts in keratinocytes. In this study, we
identiﬁed four new recurrent mutations in KIND1 in 16 individuals with Kindler syndrome from 13 families of
Pakistani (676insC), UK Caucasian (E304X), Omani (W616X), or Italian (958–1G 4 A) origins. Haplotype analysis
demonstrated common ancestral mutant alleles for each mutation, apart from one of the six Pakistani families in
which the mutation 676insC (which occurs in a repeat of seven cytosines) was present on a different genetic
background. All mutations were homozygous, apart from the three UK Caucasian cases that were all compound
heterozygotes (second allele mutations: L302X, 1161delA, 1909delA). All mutations were associated with markedly
reduced or absent skin immunostaining with an antikindlin-1 antibody. These loss-of-function KIND1 mutations
demonstrate the importance of kindlin-1 in maintaining epithelial integrity, although the mechanism linking this
mutant protein to photosensitivity and poikiloderma remains to be determined. Delineation of these recurrent
mutations is also relevant to optimizing mutation detection strategies in Kindler syndrome patients from particular
ethnic backgrounds.
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Kindler syndrome (KS) was reported first in 1954 as an
unusual inherited skin condition in a 14-y-old girl with
trauma-induced blister formation, nail dystrophy, progres-
sive poikiloderma, hyperkeratosis of the palms and soles,
webbing between toes and fingers, and sensitivity to
sunlight (Kindler, 1954). A number of similar patients have
subsequently been identified who have helped define KS as
a distinct autosomal recessive disorder (OMIM 173650).
Many of the clinical features of blistering and scarring in
children with KS resemble those seen in the inherited skin
disorder dystrophic epidermolysis bullosa, and the under-
lying skin pathology often involves morphologically and
structurally similar disruption of skin adhesion at the
dermal–epidermal junction (Fine et al, 2000). The type VII
collagen gene, COL7A1, however, which is mutated in
dystrophic epidermolysis bullosa, has been excluded as a
candidate gene for KS (Shimizu et al, 1997; Yasukawa et al,
2002). Moreover, transmission electron microscopy in KS
may reveal additional pathologic findings including blister
formation within basal keratinocytes, somewhat similar to
cases of epidermolysis bullosa simplex, a disorder known to
result from mutations in the genes encoding the intermedi-
ate filament proteins, keratins 5 or 14 (Irvine and McLean,
1999). Alternatively, there may be features of reduplication
of the lamina densa, or variable and inconsistent changes,
including multiple planes of cleavage as well as alterations
in elastic fibers (Hovnanian et al, 1989).
Similar to patients with severe forms of epidermolysis
bullosa, there is an increased risk of mucocutaneous
malignancy in KS (Couwenberg et al, 1998; Lotem et al,
2001; Mallipeddi, 2002), but there are also further clinical
differences, notably in the patients’ response to ultraviolet
irradiation. In KS, patients have an abnormal early erythema
response to sun exposure as well as signs of progressive
poikiloderma. Thus, for several years KS has been thought
to represent an unusual, but distinct, variant of epidermo-
lysis bullosa or an inherited poikiloderma syndrome.Abbreviation: KS, Kindler syndrome.
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Using genome-wide linkage analysis on DNA obtained
from consanguineous families, two groups have recently
mapped the KS gene to 20p12.3 and identified 10 different
pathogenic homozygous loss-of-function mutations in a
novel gene (Jobard et al, 2003; Siegel et al, 2003). This
gene, KIND1, encodes a 677 amino acid protein, kindlin-1. It
is well conserved throughout evolution, with closely related
homologs in Drosophila and Onchorhynchus, as well as
Caenorhabditis elegans, suggesting that it has an important
function across species (Rogalski et al, 2000; Schaller,
2000; Siegel et al, 2003). Humans possess three differen-
tially expressed kindlin genes (encoding kindlin-1, kindlin-2,
and kindlin-3), of which kindlin-1 is the major kindlin ex-
pressed by basal epidermal keratinocytes (Siegel et al, 2003).
In this study, we searched for KIND1 mutations in 16
individuals with Kindler syndrome from 13 families to extend
the mutation database and to identify any recurrent
mutations in this genodermatosis that might have relevance
to optimizing mutation detection strategies.
Results
Clinical (Fig 1) Affected individuals 1–8 were from six
Pakistani families residing in the UK. Cases 2 and 3 were
siblings, as were cases 4 and 5, but none of the six families
was known to be related to the others. Consanguinity was
present within the individual families, however. Case 1 lived in
southern England but the other families were spread across
middle and northern England. The subjects’ ages ranged
from 3 mo to 30 y, there were six males and two females, and
all had similar features of trauma-induced blistering, espe-
cially on the hands and feet, since infancy. Photosensitivity
also began in infancy and consisted of erythema within
minutes of sun exposure. Poikiloderma was often not
apparent until 8–10 y and several cases were incorrectly
diagnosed as dystrophic epidermolysis bullosa in early
childhood. Most blistering ceased during teenage years.
Thereafter, poikiloderma with prominent hyperpigmentation
and hypopigmentation was the main clinical feature. Other
features in adulthood included ectropion (cases 4 and 5) and
dysphagia (case 5). In all children under the age of 7 y, the
key investigation in establishing the diagnosis was transmis-
sion electron microscopy. Ultrastructurally, there was redu-
plication of the lamina densa, as well as variable focal areas
of collagen lysis in the superficial dermis and occasional
microclefts within the lamina lucida (data not shown).
Kindler syndrome case 9 (female; 7 y) was from the Al
Mudhabi region of Oman, whereas Omani case 10 (female;
19 y) was from the isolated island of Museira. Geographi-
cally and socially, their families were not known to be
related, although both contained consanguineous mar-
riages. The clinical features were similar to the British
Pakistani KS cases. In addition, case 10 also had dysphagia
with esophageal stenosis. There was also a history of a
sibling of case 10 dying in early infancy because of severe
skin fragility and secondary infection.
Cases 11 (male; 23 y), 12 (female; 10 y), and 13 (female;
44 y) were unrelated white Caucasians from different parts
of England. Although the clinical history of initial trauma-
induced blistering and sun sensitivity was similar to the KS
individuals above, the degree of poikiloderma was more
subtle, reflecting the paler skin type (I–II; cf. types IV–V in
subjects 1–10). The clinical features in case 11 closely
resembled a mild form of dystrophic epidermolysis bullosa
or possible non-Herlitz junctional epidermolysis bullosa, but
again, reduplication of the lamina densa seen on transmis-
sion electron microscopy provided the clue to the correct
diagnosis of KS.
Affected Italian individuals 14 and 15 were brothers (34
and 36 y) from the rural south of the country, whereas case
16 (male; 46 y) was a seemingly unrelated individual from
urban central Italy. All had trauma-induced blistering from
birth until adolescence. Features of poikiloderma were
subtle and more closely resembled postinflammatory
pigmentation. In case 16, immunohistochemical analysis
of epidermal basement membrane disclosed reduced
immunostaining for type XVII collagen, but no pathogenic
mutation has been detected in subsequent sequencing of
the COL17A1 gene (GZ, unpublished data). At the age of
43 y, case 16 developed two squamous cell carcinomas on
the upper lip and dorsum of the hand, both of which were
excised and there have been no signs of any recurrence in
3 y follow-up.
Delineation of new pathogenic KIND1 mutations in
Kindler syndrome Sequencing of genomic DNA from
affected individuals in the 13 families with KS disclosed
pathogenic mutations in each case, as shown in Fig 2. In all
affected individuals from the six Pakistani families (n¼8),
genomic DNA sequencing revealed a homozygous insertion
of cytosine at position 676 in exon 5 of KIND1, denoted
676insC (Fig 2a) (GenBank no. AY137240; nucleotide
numbers refer to cDNA with methionine initiation codon
ATG as 1–2–3, etc.). In the two Omani families, sequencing
of affected individuals’ DNA disclosed a homozygous
guanine to adenine change at nucleotide 1848 in exon 14
resulting in replacement of a tryptophan residue (TGG) by a
stop codon (TGA), denoted W616X (Fig 2b). In the three UK
Caucasian patients, sequencing showed a heterozygous
guanine to thymine change at nucleotide 910 in exon 7 that
changes a glutamic acid residue (GAA) to a stop codon
(TAA), denoted E304X (Fig 2c). Compound heterozygosity for
a further nonsense or frameshift mutation was shown in each
case. These mutations comprised a thymine to adenine
substitution at nucleotide 905 in exon 7, which changes
leucine (TTA) to a stop codon (TAA), L302X (Fig 2c); a single
nucleotide deletion in exon 10, 1161delA; and a single
nucleotide deletion in exon 15, 1909delA. In the two Italian
families, three affected individuals were homozygous for an
acceptor splice site mutation 958–1G4 A in intron 7 (Fig 2d).
These new mutations, and the previously documented
mutations in other patients with KS, are illustrated in Fig 3.
Haplotype analysis reveals evidence for recurrent
ancestral KIND1 mutations Sequencing of genomic DNA
in control and affected individuals disclosed that the KIND1
gene contains a number of highly polymorphic single
nucleotide polymorphisms. Nine intragenic single nucleo-
tide polymorphisms were identified. These comprised 1–
29T/G, 114T/C, 151þ 20C/T, 152–4G/A, 479T/C, 532þ 8T/
C, 532þ34C/T, 533–17 A/C, and 722T/C, using the
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standard numbering system described above. Haplotype
analysis of these polymorphisms in the affected individuals
showed that the mutations W616X, E304X, and 958–1G 4
A occurred on similar genetic backgrounds for each
mutation, consistent with propagation of common ancestral
alleles in the Omani, UK Caucasian, and Italian gene pools,
respectively (Table I). Likewise, in five of the six Pakistani
families, the mutation 676insC was shown on the same
allelic background. In one case (patient 1), however, the
mutated allele displayed an alternative haplotype with six
out of nine intragenic polymorphisms being different.
Immunoﬂuorescence microscopy reveals loss of ex-
pression of kindlin-1 in KS skin In control skin, immuno-
fluorescence labeling with antikindlin-1 antibody showed
bright, pan-epidermal staining, especially within the basal
keratinocyte cytoplasm and at the dermal-epidermal
junction (Fig 4a). No specific staining was seen in the
dermis. In contrast, all labeling in patient skin was markedly
reduced and in some cases absent (Fig 4b–e).
Discussion
In this study, we have identified seven new pathogenic
mutations in KIND1 in patients with KS, bringing the total
found thus far to 17, as summarized in Fig 3. Previously, two
recurrent mutations, R271X and R288X, were identified
(Siegel et al, 2003). The KIND1 mutation R271X was
demonstrated in Panamanian, Caucasian American, and
Omani subjects, whereas the mutation R288X was found in
UK Caucasian and Turkish individuals with KS. Both of
these mutations were shown on different respective genetic
backgrounds consistent with hypermutable CpG dinucleo-
tides (Cooper and Krawczak, 1993) producing potential
hotspots for loss-of-function mutations in kindlin-1. By
contrast, our study has delineated four new KIND1
mutations, 676insC, W616X, E304X, and 958–1G4A,
occurring on the same genetic background in the Pakistani,
Omani, UK Caucasian, and Italian gene pools, respectively.
These mutations indicate propagation of an ancestral allele
through different generations of these populations and are
important starting points in the investigation into the
molecular pathology of further cases of KS from the same
ethnic background. Separate from this study, we have also
identified the presence of the homozygous frameshift
mutation 1714delA in an Italian individual with KS of North
African Arabic origin (unpublished data). Interestingly, this
mutation has already been reported in another subject of
similar genetic background (Jobard et al, 2003), raising the
possibility of a further common mutated ancestral allele in
this population.
Figure1
Clinical features of Kindler syndrome. (a)
Marked poikiloderma on the dorsa of the hands
in case 4; (b) atrophy and erythema on the
dorsa of the hands in case 14; (c) trauma-
induced scars and postinflammatory hyperpig-
mentation on the lowers limbs in case 6; (d)
persistent facial erythema as a sign of photo-
sensitivity in case 6; (e) prominent poikiloderma
on the face and neck in case 5; (f) telangiecta-
siae on the lower lip mucosa in case 6; (g) skin
wrinkling and atrophy on the elbow in case 4.
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Also noteworthy from our study is the Pakistani mutation
676insC, which appears to be both a hotspot and a founder
mutation. This interpretation is supported by one individual
(patient 1) having a different genetic background in KIND1
to the other seven affected subjects. The mutation 676insC
occurs in a sequence of seven consecutive cytosines and
may therefore have arisen in patient 1 through slipped
mispairing (Cooper and Krawczak, 1993), compared to the
propagation of a mutant allele in patients 2–8 inclusive.
The immunofluorescence microscopy studies in patients
with any of these four new recurrent mutations in KIND1 (as
well as those reported by Siegel et al, 2003) demonstrate
the usefulness of the carboxy-terminal antikindlin-1 anti-
body as a potential diagnostic probe in KS. The marked
reduction (or complete absence) of immunostaining in KS
skin with this antibody appears to be a consistent and
reliable finding. From a clinical perspective, it is clear that in
nearly all the patients we studied there was a considerable
delay in establishing a correct diagnosis of KS and refuting
differential diagnoses of dystrophic epidermolysis bullosa or
a poikilodermatous genodermatosis. Thus, the new anti-
body now allows for a rapid means of diagnosing KS.
Nevertheless, it should be noted that immunostaining
was not completely absent in all KS subjects (see Fig 4).
Notably, some weak labeling was noted in patients with the
homozygous mutations 676insC and 958–1G 4 A, as well
as the individual who was a compound heterozygote for
the mutations E304X/L302X. These mutations are sited in
exon 5, intron 7, and exon 7, respectively. By contrast,
antikindlin-1 antibody labeling in skin homozygous for exon
14 mutation W616X was completely absent. The relative
differences may relate to putative alternative splicing of
KIND1 (Siegel et al, 2003). Indeed, preliminary assessment
of potential KIND1 splice variants suggests that truncated
isoforms spanning exons 2–8 and 9–15 may be expressed
in normal keratinocytes (GHSA, unpublished data). The
latter transcript would not be affected by mutations in exons
2–8 but could still react with the antibody made to the
carboxy-terminal peptide in exon 15. This might explain the
faint positive immunostaining in skin from cases with
mutations upstream from exon 8, although other factors
such as the consequences of the different mutations on
RNA processing and transcript stability may influence the
actual immunolabeling observed. From a clinicopathologic
perspective, no major phenotypic differences were noted in
patients with faint kindlin-1 immunostaining compared to
those with a complete absence of antibody labeling.
Despite the need for comprehensive characterization of
normal splice variants in KIND1, the antibody remains a
useful tool in establishing a diagnosis of KS. That said, one
of the observations in the initial study characterizing the
KIND1 gene was that some families with purported KS did
not map to the KS locus on 20p12.3 (Siegel et al, 2003). This
suggests that there may be a disorder that is clinically
similar to but genetically different from KS. We have not yet
had the opportunity to examine skin from such patients,
however, to test the specificity of the new antikindlin-1
Figure 2
Sequencing reveals recurrent nonsense and frameshift mutations
in KIND1. (a) Pakistani patients 1–8 show a homozygous insertion of a
cytosine at nucleotide 676 in exon 5, denoted 676insC. (b) Omani
patients 9 and 10 have a homozygous guanine to adenine substitution
at nucleotide 1848 in exon 14 changing a tryptophan residue (TGG) to a
stop codon (TGA), denoted W616X. (c) UK Caucasian patients 11–13
are all heterozygous for a guanine to thymine change at nucleotide 910
resulting in glutamic acid (GAA) being converted to a stop codon (TAA)
in exon 7, denoted E304X. Each of these cases has a further
heterozygous nonsense mutation on the other allele. Illustrated here
in patient 11 is a thymine to adenine substitution at nucleotide 905
changing leucine (TTA) to a stop codon (TAA), L302X, depicted by the
double arrowhead. (d) Italian patients 14–16 are homozygous for an
acceptor splice site mutation, with a substitution of guanine by adenine
in intron 7, denoted 958–1G 4 A. The start of exon 8 is indicated by an
open bracket.
Figure3
Schematic diagram showing the positions of all pathogenic
mutations found in KIND1 and their positions within the gene.
Mutations shown in bold are recurrent mutations, of which those
identified in this study are underlined. Mutations in italics are also
potential hotspot mutations. Exons (numbered 1–15) are to scale;
introns in between are not to scale. Hatched areas denote start of 50
and 30 untranslated regions.
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antibody. Similarly, one of the families reported by another
research group showed evidence of genetic linkage to the
KIND1 locus but the authors were unable to identify a
mutation in this case (Jobard et al, 2003). In cases such as
these, immunostaining for kindlin-1 in patient skin would be
very useful to establish a diagnosis of KS in the absence of
mutation data.
The predicted protein structure of kindlin-1 reveals
several domains of interest, in particular a bipartite FERM
(band 4.1, ezrin, radixin, and moesin) domain separated by
a pleckstrin homology domain, indicative of roles in plasma
membrane adhesion structures and a possible link to signal
transduction (Chishti et al, 1998; Maffucci and Falasca,
2001; Lemmon et al, 2002; Siegel et al, 2003). Kindlin-1 is
involved in linking the actin cytoskeleton to the extracellular
matrix (ECM) and has been demonstrated in vivo to locate
at the ends of filamentous actin fibers within the cell, at the
point where they insert into focal contacts, and thus to the
ECM (Siegel et al, 2003). This makes KS the first inherited
skin fragility disorder to be associated with a defect in actin
cytoskeleton ECM linkage, unlike subtypes of epidermolysis
bullosa, which are associated with defects in keratin
intermediate filament-ECM linkage. This observation may
shed light on the unusual morphology seen on transmission
electron microscopy in KS, which displays features different
to other inherited skin fragility disorders, including extensive
basement membrane reduplication (Shimizu et al, 1997;
Siegel et al, 2003). The actual mechanisms leading to
basement membrane dysregulation remain to be eluci-
dated, however. Likewise, the actin cytoskeleton–focal
contact link to the clinical features of photosensitivity,
poikiloderma, and squamous cell carcinoma is still a
mystery to be explored. Identification of the specific
interactions of kindlin-1 with other molecules by the yeast
two-hybrid system or similar strategies should shed light on
these unresolved issues.
In essence, our study expands the mutation database of
KIND1 mutations in KS, reports the utility of a new
antikindlin-1 antibody in the rapid diagnosis of KS, and
provides useful data in optimizing mutation screening in this
genodermatosis.
Materials and Methods
PCR ampliﬁcation of genomic DNA and mutation detection
Following approval by the ethics committee of St. Thomas Hospital,
London, and informed consent, DNA was extracted from periph-
eral blood samples taken from affected individuals, their parents,
and clinically normal siblings (where possible) using a standard
cold water lysis method (Sambrook et al, 1989). PCR amplification
of the KIND1 gene was performed as described elsewhere (Siegel
et al, 2003). For PCR amplification, 500 ng of genomic DNA was
used as template in an amplification buffer containing 1 mM of each
primer, 1.5 mM of MgCl2, 50 mM of each nucleotide, and 2.5 U Taq
polymerase (PE Biosystems, Warrington, UK) in a total volume of
50 mL in a PE Biosystems 9700 thermal cycler. The amplification
conditions were 951C for 5 min, followed by 35 cycles of 951C for
Table I. Ancestral KIND1 alleles associated with recurrent pathogenic mutations underlying Kindler syndrome
KIND1 polymorphism 676insC (Pakistani) E304X (UK Caucasian) W616X (Omani) 958–1G4A (Italian)
1–29T/C G T G G
114T/C C T C C
151þ 20C/T C C T T
152–4G/A G G A A
479T/C C T T T
532þ 8T/C T T C C
532þ 34T/C C C T T
533–17A/C C A A A
722T/C T T T T
Figure 4
Immunofluorescence labeling with antikindlin-1 C-terminal anti-
body. (a) Control skin shows strong epidermal labeling within the basal
keratinocytes and along the dermal–epidermal junction. (b) Patient 6,
homozygous for the mutation 676insC, shows weak basal keratinocyte
staining and broken staining along the dermal–epidermal junction. (c)
Patient 11, compound heterozygous for E304X/L302X, shows weak
staining throughout the epidermis. (d) Patient 10, homozygous for
W616X, shows absence of staining. (e) Patient 16, homozygous for
958–1G 4 A, shows weak staining throughout the epidermis. (f)
Negative control skin labeling. Bar: 40 mm.
82 ASHTON ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
45 s, annealing temperature (see Siegel et al, 2003) for 45 s, and
721C for 45 s. Aliquots (5 mL) of the PCR products were analyzed
by 2% agarose gel electrophoresis. PCR products were purified
using QIAquick PCR Purification Kit (Qiagen, Crawley, UK) and
sequenced directly using Big Dye labeling in an ABI 310 genetic
analyzer (PE Biosystems). Potential mutations were confirmed by
restriction endonuclease digestion or bidirectional sequencing and
assessed in up to 200 control chromosomes, selected to match
the patients’ ethnic backgrounds. The control samples were
selected from 3000 archival DNA samples kept within the Genetic
Skin Disease Group at St John’s Institute of Dermatology, London,
UK.
Identiﬁcation of common nonpathogenic polymorphisms in
KIND1 To search for common sequence variants in KIND1 that
would be useful for haplotype analysis, genomic DNA from 40
control individuals of mixed ethnic backgrounds was amplified
using the PCR primers and methods detailed above (and in Siegel
et al, 2003) and screened using heteroduplex analysis, as
described elsewhere (Ganguly et al, 1993). PCR products display-
ing bandshifts were then investigated further by direct nucleotide
sequencing.
Immunoﬂuorescence microscopy Skin biopsies were available
from four patients (patients 6, 10, 11, and 16). Skin was washed in
phosphate-buffered saline (PBS) for 30 min before being em-
bedded in OCT compound (TAAB, UK) and snap frozen in
isopentane cooled by liquid nitrogen. Five micron cryosections
were fixed in 1:1 acetone and methanol at 201C for 20 min, then
rehydrated in PBS for 2  15 min, and incubated in 0.1% Triton X-
100 in PBS prior to blocking with 10% normal goat serum in PBS
for 20 min. Sections were then incubated in the same well with
primary kindlin-1 rabbit polyclonal antibody for 1 h at 371C. Details
of the kindlin-1 antibody (made against the carboxy-terminal 15
amino acids) have been published elsewhere (Siegel et al, 2003).
After washing, sections were incubated with goat antirabbit Alexa
Fluor 488 conjugate (Cambridge BioSciences, Cambridge, UK) for
1 h. A negative control was treated with the same method but
replacing antikindlin-1 antibody with 10% normal goat serum. The
samples were thoroughly washed in PBS and subsequently
mounted on coverslips. Microscopy was performed using a Nikon
Optiphot Microscope with Kodak Microscopy Document System
290.
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